Berger, K. L., Lagacé, L., Triki, I., Cartier, M., Marquis, M., Lawetz, C., . . . Kukolj, G. (2013). Viral Resistance in Hepatitis C Virus Genotype 1-Infected Patients Receiving the NS3 Protease Inhibitor Faldaprevir (BI 201335) in a Phase 1b Multiple-Rising-Dose Study. American Society for Microbiology.
Citación estilo ChicagoBerger, Kristi L., Lisette Lagacé, Ibtissem Triki, Mireille Cartier, Martin Marquis, Carol Lawetz, Richard Bethell, Joseph Scherer, and George Kukolj. Viral Resistance in Hepatitis C Virus Genotype 1-Infected Patients Receiving the NS3 Protease Inhibitor Faldaprevir (BI 201335) in a Phase 1b Multiple-Rising-Dose Study. American Society for Microbiology, 2013.
Cita MLABerger, Kristi L., et al. Viral Resistance in Hepatitis C Virus Genotype 1-Infected Patients Receiving the NS3 Protease Inhibitor Faldaprevir (BI 201335) in a Phase 1b Multiple-Rising-Dose Study. American Society for Microbiology, 2013.